South Korea Genomics Market Size & Outlook, 2026-2033

Name: South Korea Genomics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The genomics market in South Korea is expected to reach a projected revenue of US$ 467.4 million by 2033. A compound annual growth rate of 18.7% is expected of South Korea genomics market from 2026 to 2033.

South Korea genomics application outlook (Revenue, USD million, 2021-2033)
- Functional Genomics
  - Real-time PCR
  - Transfection
  - SNP Analysis
  - Mutational Analysis
  - Microarray Analysis
  - RNA Interference
- Epigenomics
  - Bisulfite Sequencing
  - Microarray Analysis
  - Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
  - Methylated DNA Immunoprecipitation (MeDIP)
  - High Resolution Melt (HRM)
  - Chromatin Accessibility Assays
- Pathway Analysis
  - Microarray Analysis
  - Bead-based Analysis
  - Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
  - Real-time PCR
- Biomarker Discovery
  - DNA Sequencing
  - Microarray Analysis
  - Real-time PCR
  - Mass Spectrometry
  - Statistical Analysis
  - Bioinformatics
- Others
South Korea genomics deliverable outlook (Revenue, USD million, 2021-2033)
- Products
  - Instruments/Systems/Software
  - Consumables & Reagents
- Services
  - NGS-based Services
  - Core Genomics Services
  - Biomarker Translation Services
  - Computational Services
  - Others
South Korea genomics end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Academic and Government Institutes
- Clinical Research
- Other End Users

South Korea Genomics Market Size & Outlook, 2026-2033

Sign up - it's easy, and free!